e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Pulmonary vascular involvement in smoking and respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Smoking induced pulmonary vascular remodelling in patients with mild COPD
O. Fira-Mladinescu, L. Vasile, C. Fira-Mladinescu, C. Bunu, D. Muntean, V. Tudorache, G. Mihalas (Timisoara, Romania)
Source:
Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Session:
Pulmonary vascular involvement in smoking and respiratory diseases
Session type:
Thematic Poster Session
Number:
3564
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Fira-Mladinescu, L. Vasile, C. Fira-Mladinescu, C. Bunu, D. Muntean, V. Tudorache, G. Mihalas (Timisoara, Romania). Smoking induced pulmonary vascular remodelling in patients with mild COPD. Eur Respir J 2007; 30: Suppl. 51, 3564
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
Source: Eur Respir J 2002; 19: 632-638
Year: 2002
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension.
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Microvascular changes in COPD patients with severe pulmonary hypertension
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
Systemic inflammation and pulmonary hypertension in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007
Airways obstruction is associated with increased cardiac injury and systemic inflammation in patients with stable COPD
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Do COPD patients have a pulmonary vascular phenotype?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Pulmonary hypertension and endothelial dysfunction in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007
Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 173s
Year: 2001
Vascular dysfunction and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 226s
Year: 2007
Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Mechanisms underlying pulmonary vascular changes in COPD patients
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Pulmonary hypertension in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 892-905
Year: 2003
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Treatment of pulmonary hypertension in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313
Year: 2006
Antithrombogenic activity of a vascular wall at the patients with COPD with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 415s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept